ChemicalBook > Product Catalog >Biochemical Engineering >Polypeptide >Pramlintide acetate

Pramlintide acetate

Pramlintide acetate Structure
CAS No.
196078-30-5
Chemical Name:
Pramlintide acetate
Synonyms
Prgmlintide;pramlintide acetate;Dithranol Impurity 11;pramlintide acetate hydrate;Tripo-aMylin Acetate Hydrate;Pramlintide?Acetate impurity;Pramlintide acetate USP/EP/BP;Pramlintide Acetate, Amylin Rat;AC-137 Acetate Hydrate, SyMlin Acetate Hydrate;25-L-Proline-28-L-proline-29-L-proline-aMylin (huMan) Acetate Hydrate
CBNumber:
CB4468518
Molecular Formula:
C173H273N51O56S2
Molecular Weight:
4027.46
MOL File:
196078-30-5.mol
Modify Date:
2024/4/19 20:05:26

Pramlintide acetate Properties

Melting point >175°C (dec.)
storage temp. Refrigerator
solubility Acetic Acid (Slightly), DMSO (Slightly)
form Solid
color White to Off-White
CAS DataBase Reference 196078-30-5(CAS DataBase Reference)

Pramlintide acetate Chemical Properties,Uses,Production

Description

Pramlintide acetate is an injectable human amylin analog that has been launched for the treatment of both type 1 and type 2 diabetes, in conjunction with insulin. While it is also a 37-amino acid peptide, it differs from its parent predecessor by the substitution of Ala-25, Ser-28, and Ser-29 with prolines. Not only do these modifications improve the solubility of the peptide, they also eliminate the aggregation observed with amylin, resulting in a stable synthetic analog with retention of biological activity that is suitable for pharmaceutical use. As an indication of potency, Pramlintide acetate inhibits the binding of radioiodinated rat amylin to rat nucleus accumbens membranes with a Ki value of 23 pM. Its mechanism of action mimics amylin; as a neurohormone that is cosecreted with insulin from the pancreatic β cells in response to meals, it is involved in glucose homeostasis. Both peptides lower postprandial glucose levels by inhibiting glucagon and by restraining the vagus-mediated rate of gastric emptying, thereby, slowing intestinal carbohydrate absorption. Furthermore, amylin, orPramlintide acetate, has the added benefit of inducing postprandial satiety resulting in weight loss in the patients with type 2 diabetes. Since Pramlintide acetate slows gastric emptying, it is contraindicated in patients with gastroparesis and in patients taking drugs that alter gastrointestinal motility (anticholinergic agents, such as, atropine) or slow down the intestinal absorption of nutrients (such as α-glucosidase inhibitors). Pramlintide acetate is also contraindicated in patients with hypoglycemic tendencies; due to co-administration with insulin, severe insulin-induced hypoglycemia is a risk. The most commonly reported adverse events include nausea, vomiting, anorexia, headache, abdominal pain, fatigue, dizziness, coughing, and pharyngitis.

Chemical Properties

Pramlintide acetate is White Solid

Uses

Pramlintide acetate is an analogue of human amylin used in the treatment of insulin dependent diabetes.

Clinical Use

Pramlintide acetate is a synthetic analogue of amylin (a 37-peptide) with proline substitutions at residues 25, 28, and 29. These substitutions change its physical properties such that it is commercially available for SC injection. When pramlintide is used in combination with insulin, it slows gastric emptying, lowers blood glucose levels after meals, and affords a feeling of fullness that leads to decreased caloric intake and the potential for weight loss. Pramlintide has been approved for use in adults with type I or type II diabetes as an adjunct along with insulin. The dose is quite different for type I (15–60 μg SC before meals) and type II diabetes (60–120 μg). The drug should be refrigerated before opening and may be kept at room temperature for up to 28 days after opening.

Pramlintide acetate Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 232)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Manus Aktteva +91 (79) 6512-3395 New Delhi, India 581 34 Inquiry
SUN PHARMACEUTICAL INDUSTRIES LTD (+91 22) 4324 4324 New Delhi, India 175 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
Shanghai Getian Industrial Co., LTD +86-15373193816 +86-15373193816 China 274 58 Inquiry
ZHEJIANG JIUZHOU CHEM CO., LTD +86-0576225566889 +86-13454675544 China 19947 58 Inquiry
Shaanxi TNJONE Pharmaceutical Co., Ltd +8618740459177 China 1142 58 Inquiry
Hebei Yanxi Chemical Co., Ltd. +86-17531190177; +8617531190177 China 6011 58 Inquiry
Shanghai Yunao International Trade Co., Ltd +8617621705551 China 265 58 Inquiry
Zibo Hangyu Biotechnology Development Co., Ltd +86-0533-2185556 +8617865335152 China 11027 58 Inquiry
Nantong Guangyuan Chemicl Co,Ltd +undefined17712220823 China 616 58 Inquiry
AMYLIN (HUMAN), 25-L-PROLINE-28-L-PROLINE-29-L-PROLINE-, ACETATE (SALT), HYDRATE pramlintide acetate pramlintide acetate hydrate 25-L-Proline-28-L-proline-29-L-proline-aMylin (huMan) Acetate Hydrate AC-137 Acetate Hydrate, SyMlin Acetate Hydrate Tripo-aMylin Acetate Hydrate Pramlintide Acetate, Amylin Rat Pramlintide?Acetate impurity Pramlintide acetate USP/EP/BP Dithranol Impurity 11 Prgmlintide 196078-30-5 C171H267N51O53S2xC2H4O2xH2O C171H267N51O53S2 C171H267N51O53S2xC2H4 C2H4O2C2H6C6H14N2OC15H27N5O7C144H222N42O43H2O Amino Acids & Derivatives Bases & Related Reagents Drug Analogues Heterocycles Intermediates & Fine Chemicals Nucleotides Pharmaceuticals Peptide